CN111154750A - 一种针对性富集血浆目标游离dna的方法 - Google Patents
一种针对性富集血浆目标游离dna的方法 Download PDFInfo
- Publication number
- CN111154750A CN111154750A CN202010030251.XA CN202010030251A CN111154750A CN 111154750 A CN111154750 A CN 111154750A CN 202010030251 A CN202010030251 A CN 202010030251A CN 111154750 A CN111154750 A CN 111154750A
- Authority
- CN
- China
- Prior art keywords
- magnetic beads
- sample
- free dna
- enriching
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 239000011324 bead Substances 0.000 claims abstract description 81
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 238000005406 washing Methods 0.000 claims abstract description 19
- 238000004140 cleaning Methods 0.000 claims abstract description 9
- 238000005336 cracking Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 30
- 239000006228 supernatant Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 15
- 230000009089 cytolysis Effects 0.000 claims description 14
- 239000007983 Tris buffer Substances 0.000 claims description 13
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- -1 polyoxyethylene Polymers 0.000 claims description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 5
- 239000002736 nonionic surfactant Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920004890 Triton X-100 Polymers 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000006166 lysate Substances 0.000 claims description 4
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 4
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 4
- 210000005259 peripheral blood Anatomy 0.000 claims description 4
- 239000011886 peripheral blood Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000007984 Tris EDTA buffer Substances 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 2
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 238000007781 pre-processing Methods 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 claims description 2
- 229910001488 sodium perchlorate Inorganic materials 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 239000012634 fragment Substances 0.000 abstract description 13
- 238000003745 diagnosis Methods 0.000 abstract description 12
- 238000012216 screening Methods 0.000 abstract description 10
- 150000007523 nucleic acids Chemical group 0.000 abstract description 8
- 102000039446 nucleic acids Human genes 0.000 abstract description 6
- 108020004707 nucleic acids Proteins 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 2
- 238000011896 sensitive detection Methods 0.000 abstract description 2
- 238000010828 elution Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 12
- 230000008774 maternal effect Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- 238000007847 digital PCR Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Inorganic materials [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 102000044158 nucleic acid binding protein Human genes 0.000 description 1
- 108700020942 nucleic acid binding protein Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
实施例2 | 实施例3 | 实施例4 | |
第一次投放比例 | 25-30:1 | 20-25:1 | 40-50:1 |
第二次投放比例 | 145-150:1 | 140-145:1 | 150-155:1 |
大小范围 | 250-400bp | 400-550bp | 300-600bp |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010030251.XA CN111154750A (zh) | 2020-01-13 | 2020-01-13 | 一种针对性富集血浆目标游离dna的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010030251.XA CN111154750A (zh) | 2020-01-13 | 2020-01-13 | 一种针对性富集血浆目标游离dna的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111154750A true CN111154750A (zh) | 2020-05-15 |
Family
ID=70562541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010030251.XA Pending CN111154750A (zh) | 2020-01-13 | 2020-01-13 | 一种针对性富集血浆目标游离dna的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111154750A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113621606A (zh) * | 2021-04-25 | 2021-11-09 | 北京全式金生物技术有限公司 | 一种提取血浆游离dna的试剂盒和方法 |
CN113943728A (zh) * | 2021-12-09 | 2022-01-18 | 深圳基因家科技有限公司 | 一种核酸纯化方法 |
CN114371065A (zh) * | 2021-12-28 | 2022-04-19 | 上海固容生物科技有限公司 | 一种生物样本液体活检样本的处理方法(磁珠分离法)及其应用 |
CN114717223A (zh) * | 2022-03-29 | 2022-07-08 | 翌圣生物科技(上海)股份有限公司 | 处理生物样本的试剂及其应用 |
CN114958825A (zh) * | 2022-04-07 | 2022-08-30 | 翌圣生物科技(上海)股份有限公司 | 一种差异化富集小片段核酸分子的方法 |
WO2023186110A1 (zh) * | 2022-04-01 | 2023-10-05 | 北京贝瑞和康生物技术有限公司 | 一种富集孕妇血浆中胎儿dna的方法和试剂盒 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105112400A (zh) * | 2015-08-31 | 2015-12-02 | 臻和(北京)科技有限公司 | 一种提取游离dna的试剂盒 |
WO2016075701A2 (en) * | 2014-11-11 | 2016-05-19 | Scigenom Labs Pvt. Ltd. | A method for extraction of dna using naked magnetic nanoparticles |
CN106676098A (zh) * | 2016-11-25 | 2017-05-17 | 广州奇辉生物科技有限公司 | 一种提高核酸提取率的磁珠组合物及其应用 |
CN109852668A (zh) * | 2018-12-29 | 2019-06-07 | 苏州金唯智生物科技有限公司 | 一种简化基因组测序文库及其建库方法 |
CN109913447A (zh) * | 2019-04-04 | 2019-06-21 | 深圳市南科征途有限公司 | 游离dna提取富集试剂盒及游离dna提取方法 |
CN110317805A (zh) * | 2019-07-09 | 2019-10-11 | 杭州千基生物科技有限公司 | 一种核酸片段分选纯化试剂及方法 |
-
2020
- 2020-01-13 CN CN202010030251.XA patent/CN111154750A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016075701A2 (en) * | 2014-11-11 | 2016-05-19 | Scigenom Labs Pvt. Ltd. | A method for extraction of dna using naked magnetic nanoparticles |
CN105112400A (zh) * | 2015-08-31 | 2015-12-02 | 臻和(北京)科技有限公司 | 一种提取游离dna的试剂盒 |
CN106676098A (zh) * | 2016-11-25 | 2017-05-17 | 广州奇辉生物科技有限公司 | 一种提高核酸提取率的磁珠组合物及其应用 |
CN109852668A (zh) * | 2018-12-29 | 2019-06-07 | 苏州金唯智生物科技有限公司 | 一种简化基因组测序文库及其建库方法 |
CN109913447A (zh) * | 2019-04-04 | 2019-06-21 | 深圳市南科征途有限公司 | 游离dna提取富集试剂盒及游离dna提取方法 |
CN110317805A (zh) * | 2019-07-09 | 2019-10-11 | 杭州千基生物科技有限公司 | 一种核酸片段分选纯化试剂及方法 |
Non-Patent Citations (1)
Title |
---|
王晖等: "两步磁珠法提取血浆游离DNA 的评价及临床应用" * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113621606A (zh) * | 2021-04-25 | 2021-11-09 | 北京全式金生物技术有限公司 | 一种提取血浆游离dna的试剂盒和方法 |
CN113621606B (zh) * | 2021-04-25 | 2023-12-12 | 北京全式金生物技术股份有限公司 | 一种提取血浆游离dna的试剂盒和方法 |
CN113943728A (zh) * | 2021-12-09 | 2022-01-18 | 深圳基因家科技有限公司 | 一种核酸纯化方法 |
CN113943728B (zh) * | 2021-12-09 | 2022-12-09 | 苏州吉因加医学检验有限公司 | 一种核酸纯化方法 |
CN114371065A (zh) * | 2021-12-28 | 2022-04-19 | 上海固容生物科技有限公司 | 一种生物样本液体活检样本的处理方法(磁珠分离法)及其应用 |
CN114717223A (zh) * | 2022-03-29 | 2022-07-08 | 翌圣生物科技(上海)股份有限公司 | 处理生物样本的试剂及其应用 |
WO2023186110A1 (zh) * | 2022-04-01 | 2023-10-05 | 北京贝瑞和康生物技术有限公司 | 一种富集孕妇血浆中胎儿dna的方法和试剂盒 |
CN114958825A (zh) * | 2022-04-07 | 2022-08-30 | 翌圣生物科技(上海)股份有限公司 | 一种差异化富集小片段核酸分子的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111154750A (zh) | 一种针对性富集血浆目标游离dna的方法 | |
CN103820431B (zh) | 基于纳米磁珠的核酸提取纯化方法及试剂盒 | |
US9909118B2 (en) | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media | |
JP4036625B2 (ja) | 二本鎖/単鎖核酸構造物の分離方法 | |
Vomelova et al. | Technical note methods of RNA purification. All ways (should) lead to Rome | |
CN102229925B (zh) | 一种增强的磁珠法核酸提取方法 | |
CN106591297A (zh) | 一种磁珠法核酸提取方法 | |
CN107043766A (zh) | 一种即用型的核酸磁珠提取试剂 | |
CN106834277A (zh) | 一种用磁珠法分离游离dna的方法及分离试剂盒 | |
JP2012502632A (ja) | スモールrnaの単離法 | |
JP2008245649A (ja) | 表面における核酸の単離及び精製のための方法並びに手段 | |
JP2006311803A (ja) | 核酸精製方法、及び核酸精製器具 | |
CN113151397B (zh) | 一种基于磁珠法提取病毒样本的核酸提取试剂盒 | |
CN105695450A (zh) | 基于磁珠法提取游离dna的试剂盒及其使用方法 | |
US20220372471A1 (en) | Apparatuses systems and methods for enrichment and separation of nucleic acids by size | |
CN108026570A (zh) | 从血液样品中纯化核酸的组合物和方法 | |
CN107254465A (zh) | 一种采用磁性微球分离外周血中游离核酸的试剂盒及方法 | |
CN112899266A (zh) | 一种核酸提取用裂解结合液及其试剂盒和应用 | |
CN106754890B (zh) | 一种病毒rna的提取试剂盒和提取方法 | |
CN113913421A (zh) | 全血dna提取试剂及提取方法 | |
JP2010521988A (ja) | スルホランを用いた生体分子の分離方法 | |
JP3082908B2 (ja) | リボ核酸の単離方法 | |
CN112322615B (zh) | 核酸保存液、核酸提取保存液、采血管和提取核酸的方法 | |
CN112941067A (zh) | 一种全血核酸提取用裂解结合液及其试剂盒和应用 | |
CN109439655B (zh) | 适用于超微量细胞核酸提取的试剂盒及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200714 Address after: 230000 floor 5, workshop 4, Mingzhu Industrial Park, No. 106, intersection of innovation Avenue and Mingzhu Avenue, hi tech Zone, Hefei City, Anhui Province Applicant after: Hefei Xingzhi Biotechnology Co.,Ltd. Address before: 215000 room 1605, phase I, Guoyu building, No. 8, Dongwu North Road, Wuzhong District, Suzhou City, Jiangsu Province Applicant before: Suzhou Xingzhi Kangzhong Biotechnology Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200515 |